Skip to content

ISRAVanEck Israel ETF

Grow my money12y track recordRanked #1,412 of 2,960 in this goal

Seeks to replicate the price and yield performance of the BlueStar Israel Global Index.

By VanEck · Launched 2013

Annual Cost

0.59%

#3,001 of 5,562 · average

Fund Size

$167M

#2,445 of 5,562 · mid-size

Return (1Y)Goal

+35.4%

Track Record

12 years

#1,088 of 5,562 · established

Performance

Total-return NAV · USD
Growth of $10,000
$13,339+33.4%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Cap

Multi cap

Strategy

Index tracking

Index tracked

BlueStar Israel Global Index

What it actually holds

By weight

Concentration

Top 10 holdings = 53.4% of fundmoderately concentrated

Teva Pharmaceutical Industries Ltd
10.5%
Bank Leumi Le-Israel BM
8.4%
Bank Hapoalim BM
7.2%
CyberArk Software Ltd
6.1%
Elbit Systems Ltd
4.9%
Check Point Software Technologies Ltd
4.4%
State Street Global Advisors
3.2%
Israel Discount Bank Ltd
3.2%
Mizrahi Tefahot Bank Ltd
3.0%
Phoenix Financial Ltd
2.6%

Asset allocation

Stocks
100.0%

By sector

Financial Services
37.0%
Technology
23.4%
Healthcare
11.3%
Industrials
10.4%
Utilities
5.7%
Real Estate
4.7%
Energy
1.9%
Consumer Cyclical
1.9%
Other
3.6%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
21.2%High

Year-on-year price swings

Max drawdown
-45.0%Severe

Worst peak-to-trough loss

Sharpe (3Y)
0.91Decent risk-adjusted returns
Sortino (3Y)
1.34Good downside protection

Where to buy

Listing

Exchange
NYSE Arca

Full fund details

Objective
Seeks to replicate the price and yield performance of the BlueStar Israel Global Index.
Strategy
Invests primarily in securities that comprise the Israel Index, which includes publicly traded Israeli companies. The Fund uses a passive investment approach to replicate the Index's performance, without attempting to outperform it or taking defensive positions inconsistent with its objective.
Inception date
June 25, 2013
Fund family
VanEck

What's next?

You've reviewed ISRA. Save it to your watchlist to track it alongside the other funds you're weighing.

Data updated on 2026-06-19